MCRB Earnings

Quarterly EPS
$11.63
Q3 2024
$-1.83
Q4 2024
$3.76
Q1 2025
$-2.27
Q2 2025
$0.94
Q3 2025
$-1.66
Q4 2025
$-2.08
Q1 2026
$0.47
Q2 2026
Latest Revenue736.0K
Latest Net Income4.6M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.47736.0K4.6M—+120.7%
Q1 2026-$2.08358.0K-19913000—-155.3%
Q4 2025-$1.66438.0K-15335000—+9.3%
Q3 2025$0.94351.0K8.2M—-91.9%
Q2 2025-$2.270-19855000—+47.7%
Q1 2025$3.76032.7M—+168.5%
Q4 2024-$1.830-15637000—+71.1%
Q3 2024$11.63088.8M—+257.2%
Q2 2024-$4.340-32870000——
Q1 2024-$5.490-40133000——
Q4 2023-$6.340-41248000——
Q3 2023-$7.400-47854000——
Seres Therapeutics (MCRB) — Earnings